Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Herbs for the Treatment of Insomnia

  • Kim, Chung-Soo (College of Pharmacy and Medical Research Center (CICT)) ;
  • Han, Jin-Yi (Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Kim, Seung-Hwan (College of Physical Education, KyungHee University) ;
  • Hong, Jin-Tae (College of Pharmacy and Medical Research Center (CICT)) ;
  • Oh, Ki-Wan (College of Pharmacy and Medical Research Center (CICT))
  • Received : 2011.04.15
  • Accepted : 2011.07.04
  • Published : 2011.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Pharmacological approaches have been included in conventional medical treatment for insomnia or sleep disorders. However, long-term use of frequently prescribed medications can often lead to habituation, critical withdrawal symptoms and/or side effects. Some individuals with insomnia or trouble sleeping have used complementary and alternative medicine (CAM) therapies to treat their conditions. Recently, CAMs or herbs have been attractive alternative medications to many patients with sleep disorders who may be averse to using conventional drugs. We reviewed the most widely available sleep-promoting herbs commonly used in the western and oriental countries.

Keywords

References

  1. Abebe, W. (2002) Herbal medication: potential for adverse interactions with analgesic drugs. J. Clin. Pharm. Ther. 27, 391-401. https://doi.org/10.1046/j.1365-2710.2002.00444.x
  2. Allison, T. and Goff, W. R. (1972) Electrophysiological studies of the echidna, Tachyglossus aculeatus. 3. Sensory and interhemispheric evoked responses. Arch. Ital. Biol. 110, 195-216.
  3. Armitage, R. (1995) The distribution of EEG frequencies in REM and NREM sleep stages in healthy young adults. Sleep. 18, 334-341. https://doi.org/10.1093/sleep/18.5.334
  4. Avidan, A. Y. (2005). Sleep disorders in the older patient. Prim. Care 32, 563-586. https://doi.org/10.1016/j.pop.2005.03.001
  5. Awad, R., Levac, D., Cybulska, P., Merali, Z., Trudeau, V. L. and Arnason, J. T. (2007). Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system. Can. J. Physiol. Pharmacol. 85, 933-942. https://doi.org/10.1139/Y07-083
  6. Bailes, S., Baltzan, M., Rizzo, D., Fichten, C. S., Grad, R., Wolkove, N., Creti, L., Amsel, R. and Libman, E. (2009) Sleep disorder symptoms are common and unspoken in Canadian general practice. Fam. Pract. 26, 294-300. https://doi.org/10.1093/fampra/cmp031
  7. Balderer, G. and Borbely, A. A. (1985) Effect of valerian on human sleep. Psychopharmacol. (Berl). 87, 406-409. https://doi.org/10.1007/BF00432503
  8. Barnes, J., Anderson, L. A. and Phillipson, J. D. (2001) St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 53, 583-600. https://doi.org/10.1211/0022357011775910
  9. Benke, D., Barberis, A., Kopp, S., Altmann, K. H., Schubiger, M., Vogt, K. E., Rudolph, U. and Mohler, H. (2009) GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacol. 56, 174-181.
  10. Bennett, D. A. Jr., Phun, L., Polk, J. F., Voglino, S. A., Zlotnik, V. and Raffa, R. B. (1998) Neuropharmacology of St. John's Wort (Hypericum). Ann. Pharmacother. 32, 1201-1208. https://doi.org/10.1345/aph.18026
  11. Blatter, M., Hoigne, R., Hess, T., Bickel, M. H., Zoppi, M., Fritschy, D. and Maibach, R. (1988) [Side-effects of frequently administered hypnotics and sedatives as well as of anxiolytics. Results from a Comprehensive Hospital Drug Monitoring (CHDM) program]. Schweiz Med Wochenschr. 118, 1859-1864.
  12. Butterweck, V. (2003) Mechanism of action of St John's wort in depression: what is known? CNS Drugs 17, 539-562. https://doi.org/10.2165/00023210-200317080-00001
  13. Carrasco, M. C., Vallejo, J. R., Pardo-de-Santayana, M., Peral, D., Martin, M. A. and Altimiras, J. (2009) Interactions of Valeriana offi cinalis L. and Passifl ora incarnata L. in a patient treated with lorazepam. Phytother. Res. 23, 1795-1796. https://doi.org/10.1002/ptr.2847
  14. Cheng, D., Lidgard, R. O., Duffi eld, P. H., Duffi eld, A. M. and Brophy, J. J. (1988) Identifi cation by methane chemical ionization gas chromatography/ mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed. Environ. Mass Spectrom. 17, 371-376. https://doi.org/10.1002/bms.1200170505
  15. Cheng, H. M., Chiang, L. C., Jan, Y. M., Chen, G. W. and Li, T. C. (2010) The effi cacy and safety of a chinese herbal product (Xiao- Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int. Arch. Allergy Immunol. 155, 141-148.
  16. Cheng, J. T. (2000). Review: drug therapy in Chinese traditional medicine. J. Clin. Pharmacol. 40, 445-450. https://doi.org/10.1177/00912700022009198
  17. Choi, H. K., Xin, Z. C., Choi, Y. D., Lee, W. H., Mah, S. Y. and Kim, D. K. (1999) Safety and effi cacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int. J. Impot. Res. 11, 261-264. https://doi.org/10.1038/sj.ijir.3900431
  18. Chung, K. F. and Lee, C. K. (2002) Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents. Gen. Hosp. Psychiatry. 24, 430-435. https://doi.org/10.1016/S0163-8343(02)00210-4
  19. Daley, M., Morin, C. M., LeBlanc, M., Gregoire, J. P. and Savard, J. (2009) The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 32, 55-64.
  20. Dietz, B. M., Mahady, G. B., Pauli, G. F. and Farnsworth, N. R. (2005) Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res. Mol. Brain Res. 138, 191-197. https://doi.org/10.1016/j.molbrainres.2005.04.009
  21. Dijk, D. J. (2010) Sleep variety: physiology, psychology and epidemiology. J. Sleep Res. 19, 381-383. https://doi.org/10.1111/j.1365-2869.2010.00879.x
  22. Dinh, L. D., Simmen, U., Bueter, K. B., Bueter, B., Lundstrom, K. and Schaffner, W. (2001) Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta. Med. 67, 306-311. https://doi.org/10.1055/s-2001-14334
  23. Doi, Y., Minowa, M., Okawa, M. and Uchiyama, M. (2000) Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. J. Epidemiol. 10, 79-86. https://doi.org/10.2188/jea.10.79
  24. Dugoua, J. J., Mills, E., Perri, D. and Koren, G. (2006) Safety and effi - cacy of St. John's wort (hypericum) during pregnancy and lactation. Can. J. Clin. Pharmacol. 13, e268-276.
  25. Edwards, B. A., O'Driscoll, D. M., Ali, A., Jordan, A. S., Trinder, J. and Malhotra, A. (2010) Aging and sleep: physiology and pathophysiology. Semin. Respir. Crit. Care Med. 31, 618-633. https://doi.org/10.1055/s-0030-1265902
  26. Escourrou, P., Luriau, S., Rehel, M., Nedelcoux, H. and Lanoe, J. L. (2000) Needs and costs of sleep monitoring. Stud. Health Technol. Inform. 78, 69-85.
  27. Eytan, A., Haller, D. M., Wolff, H., Cerutti, B., Sebo, P., Bertrand, D. and Niveau, G. (2011) Psychiatric symptoms, psychological distress and somatic comorbidity among remand prisoners in Switzerland. Int. J. Law Psychiatry 34, 13-19. https://doi.org/10.1016/j.ijlp.2010.11.003
  28. Gale, C. and Oakley-Browne, M. (2004) Generalised anxiety disorder. Clin Evid. 1437-1459.
  29. Geier, F. P. and Konstantinowicz, T. (2004) Kava treatment in patients with anxiety. Phytother. Res. 18, 297-300. https://doi.org/10.1002/ptr.1422
  30. Gilbert, K. A. and Lydic, R. (1994) Pontine cholinergic reticular mechanisms cause state-dependent changes in the discharge of parabrachial neurons. Am. J. Physiol. 266, R136-150.
  31. Gobbi, M., Moia, M., Pirona, L., Morizzoni, P. and Mennini, T. (2001) In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/ benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters. Pharmacopsychiatry 34(Suppl 1), S45-48.
  32. Gurley, B. J., Swain, A., Hubbard, M. A., Williams, D. K., Barone, G., Hartsfi eld, F., Tong, Y., Carrier, D. J., Cheboyina, S. and Battu, S. K. (2008) Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol. Nutr. Food Res. 52, 755-763. https://doi.org/10.1002/mnfr.200600300
  33. Harris, C. D. (2005) Neurophysiology of sleep and wakefulness. Respir. Care Clin. N. Am. 11, 567-586.
  34. Hartley, D. E., Elsabagh, S. and File, S. E. (2004) Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr. Neurosci. 7, 325-333. https://doi.org/10.1080/10284150400015557
  35. Hayaishi, O. (2000) Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 355, 275-280. https://doi.org/10.1098/rstb.2000.0564
  36. Huang, L., Liu, J., Li, D., Wang, Z., Ye, W., Cai, B., Liu, M. and Li, M. (1991) A study on components and compound prescription of huangqin decoction. Zhongguo. Zhong. Yao. Za. Zhi. 16, 177-181, back cover.
  37. Kabalak, A. A., Soyal, O. B., Urfalioglu, A., Saracoglu, F. and Gogus, N. (2004) Menometrorrhagia and tachyarrhythmia after using oral and topical ginseng. J. Womens Health (Larchmt) 13, 830-833. https://doi.org/10.1089/jwh.2004.13.830
  38. Kaku, T., Miyata, T., Uruno, T., Sako, I. and Kinoshita, A. (1975) Chemico- pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part. Arzneimittelforschung 25, 539-547.
  39. Khom, S., Baburin, I., Timin, E., Hohaus, A., Trauner, G., Kopp, B. and Hering, S. (2007) Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specifi city. Neuropharmacol. 53, 178-187. https://doi.org/10.1016/j.neuropharm.2007.04.018
  40. Kimura, T., Saunders, P. A., Kim, H. S., Rheu, H. M., Oh, K. W. and Ho, I. K. (1994) Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. Gen. Pharmacol. 25, 193-199. https://doi.org/10.1016/0306-3623(94)90032-9
  41. Koetter, U., Schrader, E., Kaufeler, R. and Brattstrom, A. (2007) A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical effi cacy of a fi xed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother. Res. 21, 847-851. https://doi.org/10.1002/ptr.2167
  42. Krenn, L. (2002) Passion Flower (Passifl ora incarnata L.)--a reliable herbal sedative. Wien. Med. Wochenschr. 152, 404-406. https://doi.org/10.1046/j.1563-258X.2002.02062.x
  43. Kubin, A., Wierrani, F., Burner, U., Alth, G. and Grunberger, W. (2005). Hypericin--the facts about a controversial agent. Curr. Pharm. Des. 11, 233-253. https://doi.org/10.2174/1381612053382287
  44. Kuroda, K., Inoue, N., Ito, Y., Kubota, K., Sugimoto, A., Kakuda, T. and Fushiki, T. (2005) Sedative effects of the jasmine tea odor and (R)- (-)-linalool, one of its major odor components, on autonomic nerve activity and mood states. Eur. J. Appl. Physiol. 95, 107-114. https://doi.org/10.1007/s00421-005-1402-8
  45. Langosch, J. M., Zhou, X. Y., Heinen, M., Kupferschmid, S., Chatterjee, S. S., Noldner, M. and Walden, J. (2002) St John's wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors. Eur. Neuropsychopharmacol. 12, 209-216.
  46. Lanquart, J. P., Kerkhofs, M., Stanus, E., Mendlewicz, J. and Linkowski, P. (1996) Sleep EEG analysis by linear prediction: frequency changes of slow-wave activity within NREM and REM sleep episodes in healthy men. Neuropsychobiol. 34, 1-8.
  47. Larzelere, M. M. and Wiseman, P. (2002) Anxiety, depression, and insomnia. Prim Care 29, 339-360, vii. https://doi.org/10.1016/S0095-4543(01)00003-3
  48. Lee, S. P., Honda, K., Rhee, Y. H. and Inoue, S. (1990) Chronic intake of panax ginseng extract stabilizes sleep and wakefulness in fooddeprived rats. Neurosci. Lett. 111, 217-221. https://doi.org/10.1016/0304-3940(90)90371-F
  49. Lee, S. S., Lin, B. F. and Liu, K. C. (1996) Three triterpene esters from Zizyphus jujuba. Phytochemistry 43, 847-851. https://doi.org/10.1016/0031-9422(96)00379-2
  50. Liu, Y. W., Li, J. and Ye, J. H. (2010) Histamine regulates activities of neurons in the ventrolateral preoptic nucleus. J. Physiol. 588, 4103-4116. https://doi.org/10.1113/jphysiol.2010.193904
  51. Ma, Y., Eun, J. S., Cheong, J. H., Rhee, D. K., Hong, J. T. and Oh, K. W. (2008) Korea Red Ginseng Alters Electroencephalogram Spectra of Sleep-Wake Stage in Rats. J. Ginseng Res. 32, 179-281. https://doi.org/10.5142/JGR.2008.32.3.220
  52. Ma, Y., Han, H., Eun, J. S., Kim, H. C., Hong, J. T. and Oh, K. W. (2007) Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital- induced sleeping behaviors through the modifi cation of GABA-ergic systems. Biol. Pharm. Bull. 30, 1748-1753. https://doi.org/10.1248/bpb.30.1748
  53. Ma, Y., Ma, H., Eun, J. S., Nam, S. Y., Kim, Y. B., Hong, J. T., Lee, M. K. and Oh, K. W. (2009) Methanol extract of Longanae Arillus augments pentobarbital-induced sleep behaviors through the modifi - cation of GABAergic systems. J. Ethnopharmacol. 122, 245-250. https://doi.org/10.1016/j.jep.2009.01.012
  54. McCarley, R. W. (2007) Neurobiology of REM and NREM sleep. Sleep Med. 8, 302-330. https://doi.org/10.1016/j.sleep.2007.03.005
  55. McGinty, D. and Szymusiak, R. (2001) Brain structures and mechanisms involved in the generation of NREM sleep: focus on the preoptic hypothalamus. Sleep Med. Rev. 5, 323-342. https://doi.org/10.1053/smrv.2001.0170
  56. Meier, P. J., Ziegler, W. H. and Neftel, K. (1988) Benzodiazepine--practice and problems of its use. Schweiz Med. Wochenschr. 118, 381-392.
  57. Mendelson, W. B. (2001) Neurotransmitters and sleep. J. Clin. Psychiatry 62(Suppl 10), 5-8.
  58. Meolie, A. L., Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, R. N., Fayle, R., Troell, R., Townsend, D., Claman, D., Hoban, T. and Mahowald, M. (2005) Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J. Clin. Sleep Med. 1, 173-187.
  59. Monti, J. M. and Jantos, H. (2004) Effects of the 5-HT1A receptor ligands fl esinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. Behav. Brain Res. 151, 159-166. https://doi.org/10.1016/j.bbr.2003.08.023
  60. Nassiri-Asl, M., Shariati-Rad, S. and Zamansoltani, F. (2007) Anticonvulsant effects of aerial parts of Passifl ora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern. Med. 7, 26. https://doi.org/10.1186/1472-6882-7-26
  61. Naude, D. F., Stephanie Couchman, I. M. and Maharaj, A. (2010) Chronic primary insomnia: effi cacy of homeopathic simillimum. Homeopathy 99, 63-68. https://doi.org/10.1016/j.homp.2009.11.001
  62. Nguyen, T. T., Matsumoto, K., Yamasaki, K., Nguyen, M. D., Nguyen, T. N. and Watanabe, H. (1996) Effects of majonoside-R2 on pentobarbital sleep and gastric lesion in psychologically stressed mice. Pharmacol. Biochem. Behav. 53, 957-963. https://doi.org/10.1016/0091-3057(95)02147-7
  63. Ohta, T. (1996) Recent progress in development of psychotropic drugs (5)--Hypnotics. Nihon Shinkei Seishin Yakurigaku Zasshi 16, 161-170.
  64. Okuyama, E., Ebihara, H., Takeuchi, H. and Yamazaki, M. (1999) Adenosine, the anxiolytic-like principle of the Arillus of Euphoria longana. Planta. Med. 65, 115-119. https://doi.org/10.1055/s-1999-14055
  65. Pallesen, S., Bjorvatn, B., Nordhus, I. H. and Skjerve, A. (2002) Valerian as a sleeping aid?. Tidsskr. Nor. Laegeforen. 122, 2857-2859.
  66. Pearson, N. J., Johnson, L. L. and Nahin, R. L. (2006) Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Arch. Intern. Med. 166, 1775-1782. https://doi.org/10.1001/archinte.166.16.1775
  67. Perez, N. M. and Benedito, M. A. (1997) Activities of monoamine oxidase (MAO) A and B in discrete regions of rat brain after rapid eye movement (REM) sleep deprivation. Pharmacol. Biochem. Behav. 58, 605-608. https://doi.org/10.1016/S0091-3057(97)10002-8
  68. Ramesh, V., Thakkar, M. M., Strecker, R. E., Basheer, R. and McCarley, R. W. (2004) Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats. Behav. Brain Res. 152, 271-278. https://doi.org/10.1016/j.bbr.2003.10.031
  69. Rangkadilok, N., Worasuttayangkurn, L., Bennett, R. N. and Satayavivad, J. (2005) Identifi cation and quantifi cation of polyphenolic compounds in Longan (Euphoria longana Lam.) fruit. J. Agric. Food Chem. 53, 1387-1392. https://doi.org/10.1021/jf0403484
  70. Rhee, Y. H., Lee, S. P., Honda, K. and Inoue, S. (1990) Panax ginseng extract modulates sleep in unrestrained rats. Psychopharmacol. (Berl). 101, 486-488. https://doi.org/10.1007/BF02244226
  71. Saper, C. B., Chou, T. C. and Scammell, T. E. (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 24, 726-731. https://doi.org/10.1016/S0166-2236(00)02002-6
  72. Sharpley, A. L., McGavin, C. L., Whale, R. and Cowen, P. J. (1998) Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram. Psychopharmacol. (Berl). 139, 286-287. https://doi.org/10.1007/s002130050718
  73. Sherin, J. E., Elmquist, J. K., Torrealba, F. and Saper, C. B. (1998) Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 18, 4705-4721.
  74. Shinomiya, K., Inoue, T., Utsu, Y., Tokunaga, S., Masuoka, T., Ohmori, A. and Kamei, C. (2005) Hypnotic activities of chamomile and passifl ora extracts in sleep-disturbed rats. Biol. Pharm. Bull. 28, 808-810. https://doi.org/10.1248/bpb.28.808
  75. Shouse, M. N., Staba, R. J., Saquib, S. F. and Farber, P. R. (2000) Monoamines and sleep: microdialysis fi ndings in pons and amygdala. Brain Res. 860, 181-189. https://doi.org/10.1016/S0006-8993(00)02013-8
  76. Soulimani, R., Younos, C., Jarmouni, S., Bousta, D., Misslin, R. and Mortier, F. (1997) Behavioural effects of Passifl ora incarnata L. and its indole alkaloid and fl avonoid derivatives and maltol in the mouse. J. Ethnopharmacol. 57, 11-20. https://doi.org/10.1016/S0378-8741(97)00042-1
  77. Stanley, N. (2003) Actigraphy in human psychopharmacology: a review. Hum. Psychopharmacol. 18, 39-49. https://doi.org/10.1002/hup.471
  78. Steinfels, G. F., Young, G. A. and Khazan, N. (1980) Diurnal variations in REM and NREM sleep EEG power spectra in the rat. Brain Res. 181, 425-432. https://doi.org/10.1016/0006-8993(80)90624-1
  79. Steininger, T. L., Alam, M. N., Gong, H., Szymusiak, R. and McGinty, D. (1999) Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res. 840, 138-147. https://doi.org/10.1016/S0006-8993(99)01648-0
  80. Suntsova, N., Kumar, S., Guzman-Marin, R., Alam, M. N., Szymusiak, R. and McGinty, D. (2009) A role for the preoptic sleep-promoting system in absence epilepsy. Neurobiol. Dis. 36, 126-141. https://doi.org/10.1016/j.nbd.2009.07.005
  81. Szymusiak, R. and McGinty, D. (2008) Hypothalamic regulation of sleep and arousal. Ann. N. Y. Acad. Sci. 1129, 275-286. https://doi.org/10.1196/annals.1417.027
  82. Szymusiak, R., Steininger, T., Alam, N. and McGinty, D. (2001) Preoptic area sleep-regulating mechanisms. Arch. Ital. Biol. 139, 77-92.
  83. Tadros, M. G., Mohamed, M. R., Youssef, A. M., Sabry, G. M., Sabry, N. A. and Khalifa, A. E. (2009) Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition defi cit: a possible role of hyperforin. Behav. Brain Res. 199, 334-339. https://doi.org/10.1016/j.bbr.2008.12.015
  84. Taibi, D. M., Vitiello, M. V., Barsness, S., Elmer, G. W., Anderson, G. D. and Landis, C. A. (2009) A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med. 10, 319-328. https://doi.org/10.1016/j.sleep.2008.02.001
  85. Takagi, K., Saito, H. and Tsuchiya, M. (1972) Pharmacological studies of Panax Ginseng root: pharmacological properties of a crude saponin fraction. Jpn. J. Pharmacol. 22, 339-346. https://doi.org/10.1254/jjp.22.339
  86. Takahashi, K., Kayama, Y., Lin, J. S. and Sakai, K. (2010) Locus coeruleus neuronal activity during the sleep-waking cycle in mice. Neurosci. 169, 1115-1126. https://doi.org/10.1016/j.neuroscience.2010.06.009
  87. Teufel-Mayer, R. and Gleitz, J. (1997) Effects of long-term administration of hypericum extracts on the affi nity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors. Pharmacopsychiatry 30 Suppl 2, 113-116.
  88. Trauner, G., Khom, S., Baburin, I., Benedek, B., Hering, S. and Kopp, B. (2008) Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. Planta. Med. 74, 19-24. https://doi.org/10.1055/s-2007-993761
  89. Vazquez, I. and Aguera-Ortiz, L. F. (2002) Herbal products and serious side effects: a case of ginseng-induced manic episode. Acta. Psychiatr. Scand. 105, 76-77; discussion 77-78.
  90. Wang, W. K., Hsu, T. L., Huang, Z. Y. and Wang, Y. Y. (1995) Collective effect of a Chinese formula--a study of xiao-jian-zhong-tang. Am. J. Chin. Med. 23, 299-304. https://doi.org/10.1142/S0192415X95000353
  91. Wheatley, D. (2001a) Kava and valerian in the treatment of stressinduced insomnia. Phytother. Res. 15, 549-551. https://doi.org/10.1002/ptr.840
  92. Wheatley, D. (2001b) Stress-induced insomnia treated with kava and valerian: singly and in combination. Hum. Psychopharmacol. 16, 353-356. https://doi.org/10.1002/hup.299
  93. Wheatley, D. (2005) Medicinal plants for insomnia: a review of their pharmacology, effi cacy and tolerability. J. Psychopharmacol. 19, 414-421. https://doi.org/10.1177/0269881105053309
  94. Wu, T. Y., Chen, C. P. and Jinn, T. R. (2010) Alzheimer's disease: aging, insomnia and epigenetics. Taiwan J. Obstet. Gynecol. 49, 468-472. https://doi.org/10.1016/S1028-4559(10)60099-X
  95. Xuan, T. D., Fukuta, M., Wei, A. C., Elzaawely, A. A., Khanh, T. D. and Tawata, S. (2008) Effi cacy of extracting solvents to chemical components of kava (Piper methysticum) roots. J. Nat. Med. 62, 188-194. https://doi.org/10.1007/s11418-007-0203-2
  96. Yang, S. L., Nam, S. Y., Han, J. Y., Kim, J. C., Lee, K., Hong, J. T., Oh, K. W. and Eun, J. S. (2010) Alterations and spontaneous sleep architecture and cortical electroencephalogram power spectra by red ginseng extract via GABAAergic systems. J. Ginseng Res. 34, 304-313. https://doi.org/10.5142/jgr.2010.34.4.304
  97. Yi, P. L., Lin, C. P., Tsai, C. H., Lin, J. G. and Chang, F. C. (2007) The involvement of serotonin receptors in suanzaorentang-induced sleep alteration. J. Biomed. Sci. 14, 829-840. https://doi.org/10.1007/s11373-007-9197-8
  98. Yoo, D. Y., Choi, J. H., Kim, W., Yoo, K. Y., Lee, C. H., Yoon, Y. S., Won, M. H. and Hwang, I. K. (2011) Effects of Melissa offi cinalis L. (lemon balm) extract on neurogenesis associated with serum corticosterone and GABA in the mouse dentate gyrus. Neurochem. Res. 36, 250-257. https://doi.org/10.1007/s11064-010-0312-2
  99. Yuan, C. S., Dey, L., Wang, A., Mehendale, S., Xie, J. T., Aung, H. H. and Ang-Lee, M. K. (2002) Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation. Planta. Med. 68, 1092-1096. https://doi.org/10.1055/s-2002-36338

Cited by

  1. 3,4,5-Trimethoxycinnamic acid (TMCA), one of the constituents of Polygalae Radix enhances pentobarbital-induced sleeping behaviors via GABAAergic systems in mice vol.36, pp.10, 2013, https://doi.org/10.1007/s12272-013-0167-6
  2. Repeated Administration of Korea Red Ginseng Extract Increases Non-Rapid Eye Movement Sleep via GABAAergic Systems vol.36, pp.4, 2012, https://doi.org/10.5142/jgr.2012.36.4.403
  3. Perceived health properties of wild and cultivated food plants in local and popular traditions of Italy: A review vol.146, pp.3, 2013, https://doi.org/10.1016/j.jep.2013.01.036
  4. Rhynchophylline, One of Major Constituents ofUncariae Ramulus et UncusEnhances Pentobarbital-induced Sleep Behaviors and Rapid Eye Movement Sleep in Rodents vol.22, pp.4, 2016, https://doi.org/10.20307/nps.2016.22.4.263
  5. Cordycepin Increases Nonrapid Eye Movement Sleep via Adenosine Receptors in Rats vol.2013, 2013, https://doi.org/10.1155/2013/840134
  6. Potentiation of decursinol angelate on pentobarbital-induced sleeping behaviorsviathe activation of GABAA-ergic systems in rodents vol.21, pp.1, 2017, https://doi.org/10.4196/kjpp.2017.21.1.27
  7. Potentiates Pentobarbital-Induced Sleep Behaviors and Non-Rapid Eye Movement (NREM) Sleep in Rodents vol.25, pp.6, 2017, https://doi.org/10.4062/biomolther.2017.157
  8. Moringa oleifera Lam Seed Oil Augments Pentobarbital-Induced Sleeping Behaviors in Mice via GABAergic Systems vol.68, pp.10, 2011, https://doi.org/10.1021/acs.jafc.0c00037
  9. GABAA Receptor-Mediated Sleep-Promoting Effect of Saaz-Saphir Hops Mixture Containing Xanthohumol and Humulone vol.26, pp.23, 2021, https://doi.org/10.3390/molecules26237108